D. Wielbo et al., ANTISENSE INHIBITION OF ANGIOTENSINOGEN IN HEPATOMA-CELL CULTURE IS ENHANCED BY CATIONIC LIPOSOME DELIVERY, Biochemical and biophysical research communications, 232(3), 1997, pp. 794-799
Abnormalities in expression of renin angiotensin system components, in
cluding angiotensinogen, have been implicated in the development and m
aintenance of hypertension in the spontaneously hypertensive rat model
of hypertension. Antisense compounds are being used as physiological
tools to provide information on cardiovascular function and hypertensi
on and also show great potential for development as therapeutic agents
. We have previously shown that peripheral administration of antisense
oligonucleotides to angiotensinogen in vivo decreases hypertensive bl
ood pressures with concomitant changes in angiotensinogen protein and
angiotensin II. However, studies using naked phosphorothioated oligonu
cleotide targeted to the same region did not produce changes in angiot
ensinogen mRNA in vivo or in cell culture. We now provide data which s
how that enhanced oligonucleotide delivery utilizing cationic liposome
s significantly increases the attenuation of angiotensinogen protein a
nd decreases mRNA in a dose dependent manner. These data provide an un
derstanding of the mechanism of action of the antisense oligonucleotid
e and also establish optimal conditions and doses for further studies.
(C) 1997 Academic Press